HeartSciences Inc. Quarterly Debt-to-equity in % from Q4 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: HeartSciences Inc. quarterly Debt-to-equity history and growth rate from Q4 2022 to Q3 2024.
HeartSciences Inc. Debt-to-equity for the quarter ending October 31, 2024 was 40 %.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	40	+674		Oct 31, 2024
Q2 2024	52.5	-2.49K	-97.9%	Jul 31, 2024
Q1 2024	83.4	-251	-75%	Apr 30, 2024
Q4 2023	185	+963		Jan 31, 2024
Q3 2023	-634			Oct 31, 2023
Q2 2023	2.54K			Jul 31, 2023
Q1 2023	334			Apr 30, 2023
Q4 2022	-779			Jan 31, 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.